CareDx (CDNA) Tops Q2 EPS by 9c

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $67.55 million.

GUIDANCE:

CareDx sees FY2021 revenue of $280-290 million, versus the consensus of $278.4 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Honeywell (HON) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY Guidance
• WNS Holdings (WNS) Tops Q4 EPS by 6c, provides guidance
• Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up